Literature DB >> 31949671

Expression of NF-κB and TLR-4 is associated with the occurrence, progression and prognosis of esophageal squamous cell carcinoma.

Xiang Li1, Haiying Li1, Xiuli Dong1, Xiaoming Wang1, Junhan Zhu1, Yaozhen Cheng1, Ping Fan1.   

Abstract

BACKGROUND: As a crucial regulator of inflammation and immune responses, the NF-κB transcription factor regulates the transcription of target genes which are closely related with cell survival, cell proliferation, apoptosis, invasion and metastasis. The toll-like receptor (TLR) family is critical in aiding pathogen recognition and the subsequent activation of innate immunity. TLR4, one of the TLR family members, is the main receptor of innate immunity and functions to identify pathogens. However, the significance of the expressions of both NF-κB and TLR-4 in the occurrence, development and prognosis of esophageal squamous cell carcinoma (ESCC) remains unclear.
METHODS: NF-κB and TLR-4 expressions were analyzed in tissue microarrays made up of low grade intraepithelial neoplasia (LGIN), high grade intraepithelial neoplasia (HGIN), early-stage ESCC, advanced ESCC tissue samples, as well as normal healthy esophageal mucosa. Chi-squared tests and Kaplan-Meier plots were utilized to determine the prognostic values of the NF-κB and TLR-4 expressions.
RESULTS: We discovered that NF-κB and TLR-4 expressions were progressively increasing from normal esophageal mucosa, LGIN, HGIN and were highest in early-stage ESCC. Interestingly, TLR-4 and NF-κB expressions were attenuated in advanced ESCC tissue. Suppressed expressions of TLR-4 and NF-κB correlated to increasingly malignant ESCC. Additionally, there was a positive correlation between NF-κB and TLR-4 expressions.
CONCLUSION: TLR-4 and NF-κB are associated with the occurrence, development and malignant evolution of ESCC. IJCEP
Copyright © 2018.

Entities:  

Keywords:  NF-κB; esophageal squamous cell carcinoma; prognosis; toll-like receptor-4

Year:  2018        PMID: 31949671      PMCID: PMC6963060     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

Review 2.  Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB.

Authors:  Simon Hallam; Monica Escorcio-Correia; Robin Soper; Anne Schultheiss; Thorsten Hagemann
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

Review 3.  NF-κB, an active player in human cancers.

Authors:  Yifeng Xia; Shen Shen; Inder M Verma
Journal:  Cancer Immunol Res       Date:  2014-09       Impact factor: 11.151

Review 4.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 6.  Inflammation and colon cancer.

Authors:  Janos Terzić; Sergei Grivennikov; Eliad Karin; Michael Karin
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 7.  Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases.

Authors:  P B Ernst; H Takaishi; S E Crowe
Journal:  Dig Dis       Date:  2001       Impact factor: 2.404

Review 8.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

Review 9.  Multiple management modalities in esophageal cancer: combined modality management approaches.

Authors:  Mary Koshy; Natia Esiashvilli; Jerome C Landry; Charles R Thomas; Richard H Matthews
Journal:  Oncologist       Date:  2004

10.  Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC.

Authors:  Hongyun Gao; Lishan Wang; Shitao Cui; Mingsong Wang
Journal:  Genet Mol Biol       Date:  2012-06-23       Impact factor: 1.771

View more
  3 in total

1.  TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese population.

Authors:  Jiaying Li; Hongjiao Wu; Hui Gao; Ruihuan Kou; Yuning Xie; Zhi Zhang; Xuemei Zhang
Journal:  PeerJ       Date:  2021-02-01       Impact factor: 2.984

Review 2.  Apoptosis and Cell Proliferation Markers in Inflammatory-Fibroproliferative Diseases of the Vessel Wall (Review).

Authors:  E A Klimentova; I A Suchkov; A A Egorov; R E Kalinin
Journal:  Sovrem Tekhnologii Med       Date:  2020-08-27

3.  The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Shrabon Hasnat; Roosa Hujanen; Bright I Nwaru; Tuula Salo; Abdelhakim Salem
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.